Augmented Reality for Subdural Drain Placement

Status Not yet recruiting

Clinical Trial Summary

This study involves using a augmented reality (AR) system to assist in the placement of a subdural evacuating portal system (SEPS). In the first part of the study, all participants will have skin marking of an AR-guided and non-AR-guided site to determine feasibility and method accuracy. In the second part, subjects will be randomized to AR-guided and non-AR-guided SEPS placement to determine efficacy.

Clinical Trial Description

Chronic/subacute subdural hematoma (SDH) is one of the most common diseases encountered in neurosurgical practice. However, there is little consensus on first-line treatment. The SEPS was developed to implement a minimally invasive approach to drainage. New imaging technologies, such as augmented reality (AR) interfaces, can provide anatomical models and can help visualize hidden structures. The hope is that this study can give insight on whether AR-guidance can be used to improve SEPS placement, which can lead to higher volume drainage, greater symptomatic improvement, and decreased hospital stay. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT06052124
Study type	Interventional
Source	Stanford University
Contact
Status	Not yet recruiting
Phase	N/A
Start date	November 2023
Completion date	December 2025

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT04402632` - Embolization of the Middle Meningeal Artery With ONYX™ Liquid Embolic System for Subacute and Chronic Subdural Hematoma	N/A
Completed	`NCT03496545` - Efficacy of Bromocriptine For Fever Reduction in Acute Neurologic Injury	Phase 1/Phase 2
Terminated	`NCT05472766` - Anticoagulation Therapy Timing in Atrial Fibrillation After Acute and Chronic Subdural Hematoma	N/A
Completed	`NCT02368366` - Comparative Effectiveness of Family Problem-Solving Therapy (F-PST) for Adolescent TBI	N/A
Terminated	`NCT01463878` - Enteral Nutrition and Glycemic Variability Neurological Intensive Care Unit Study	Phase 4
Not yet recruiting	`NCT06119932` - Evaluation of One Burr Hole Evacuation for Subdural Hematoma
Completed	`NCT02618382` - A Study on the Safety of Tranexamic Acid for the Chronic Subdural Hematoma Population	Phase 4
Recruiting	`NCT04923984` - Embolization of Middle Meningeal Artery for Subdural Hematoma in Canada (EMMA Can)	N/A
Completed	`NCT03153150` - Start or STop Anticoagulants Randomised Trial (SoSTART)	Phase 3
Completed	`NCT04270955` - Dartmouth Middle Meningeal Embolization Trial (DaMMET)	N/A
Recruiting	`NCT06067750` - Comparison of Narcotrend and Cerebral Function Analysing Monitor in Intensive Care to Monitor Seizures and Deep Sedation
Not yet recruiting	`NCT05713630` - The Use of Tranexamic Acid in the Treatment of Symptomatic Subdural Hematoma	Phase 3
Withdrawn	`NCT01605357` - Hypernatremia for the Prevention and Treatment of Cerebral Edema in Traumatic Brain Injury	Phase 1/Phase 2
Withdrawn	`NCT04500795` - Prospective Study on the Use of Middle Meningeal Artery Embolization for Chronic Subdural Haematoma	N/A
Recruiting	`NCT04170582` - Patient Registry for Patients With Chronic Subdural Hematoma
Recruiting	`NCT05649904` - AFFECT Study for Patients With Intraventricular Hemorrhage, Subarachnoid Hemorrhage, Subdural Hematoma, and Ventriculitis	N/A
Recruiting	`NCT04211233` - Diagnostic Subdural EEG-electrode And Subdural hEmatoma (DISEASE)	N/A